- Home
- BBIO vs INTA Comparison
BBIO vs INTA Comparison
Compare BBIO & INTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- INTA
- Stock Information
- Founded
- BBIO 2015
- INTA 2000
- Country
- BBIO United States
- INTA United States
- Employees
- BBIO N/A
- INTA N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- INTA Computer Software: Prepackaged Software
- Sector
- BBIO Health Care
- INTA Technology
- Exchange
- BBIO Nasdaq
- INTA Nasdaq
- Market Cap
- BBIO 4.9B
- INTA 4.4B
- IPO Year
- BBIO 2019
- INTA 2021
- Fundamental
- Price
- BBIO $23.24
- INTA $59.15
- Analyst Decision
- BBIO Strong Buy
- INTA Strong Buy
- Analyst Count
- BBIO 13
- INTA 12
- Target Price
- BBIO $46.92
- INTA $53.82
- AVG Volume (30 Days)
- BBIO 1.7M
- INTA 628.3K
- Earning Date
- BBIO 11-12-2024
- INTA 11-04-2024
- Dividend Yield
- BBIO N/A
- INTA N/A
- EPS Growth
- BBIO N/A
- INTA N/A
- EPS
- BBIO N/A
- INTA N/A
- Revenue
- BBIO $217,765,000.00
- INTA $447,753,000.00
- Revenue This Year
- BBIO $3,690.39
- INTA $17.72
- Revenue Next Year
- BBIO N/A
- INTA $14.96
- P/E Ratio
- BBIO N/A
- INTA N/A
- Revenue Growth
- BBIO 2209.77
- INTA 20.07
- 52 Week Low
- BBIO $21.62
- INTA $30.36
- 52 Week High
- BBIO $44.32
- INTA $60.89
- Technical
- Relative Strength Index (RSI)
- BBIO 41.84
- INTA 69.19
- Support Level
- BBIO $21.72
- INTA $55.70
- Resistance Level
- BBIO $27.57
- INTA $60.89
- Average True Range (ATR)
- BBIO 1.42
- INTA 2.41
- MACD
- BBIO -0.23
- INTA 0.02
- Stochastic Oscillator
- BBIO 25.98
- INTA 85.90
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, acoramidis (AG10), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About INTA Intapp Inc.
Intapp Inc is a provider of industry-specific, cloud-based software solutions for the professional and financial services industry. It empowers private capital, investment banking, legal, accounting, and consulting firms with the technology needed to meet rapidly changing client, investor, and regulatory requirements. Geographically, it derives a majority of its revenue from the United States and also has a presence in the United Kingdom and the Rest of the world.